Methotrexate vs Osimertinib
Methotrexate vs Osimertinib: Overview
This comparison examines the pharmacological differences between Methotrexate and Osimertinib.
Mechanism of Action
Methotrexate: Dihydrofolate reductase inhibitor.
Osimertinib: Third-generation irreversible EGFR TKI targeting T790M resistance mutation and activating mutations.
Pharmacokinetics
Half-life: Methotrexate β 3-10 hours; Osimertinib β 48 hours.
Chemical Properties
Molecular Formula: Methotrexate β C20H22N8O5; Osimertinib β C28H33N7O2.
Molecular Weight: Methotrexate β 454.4400 g/mol; Osimertinib β 499.6050 g/mol.
Type: Methotrexate β Small molecule; Osimertinib β Small molecule.